跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
J-27
首页
药物
J-27
J-27
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
MARKED FATTY ACID DERIVATIVE, PRECURSOR COMPOUND THEREOF, AND USE THEREOF IN CONTRAST AGENT
US 20250114486 A1
申请人: UNIV BEIJING NORMAL
优先权: 2022
CN
EP
US
3 件公开
Peptides with affinity for a phospholipid and uses
US 2006148689 A1
申请人: UNIV PARIS CURIE
优先权: 2002
US
Marked peptides having affinity for a phospholipid and uses
US 2006233706 A1
申请人: UNIV PARIS CURIE
优先权: 2002
US
Heterocycle-bearing onium salts
US 2005233253 A1
申请人: WAKO PURE CHEM IND LTD
优先权: 2002
US
Aminocyclopentyl pyridopyrazinone modulators of chemokine receptor activity
US 2007155731 A1
申请人: BUTORA GABOR
优先权: 2005
US
Amino heterocyclic modulators of chemokine receptor activity
US 2007149529 A1
申请人: YANG LIHU
优先权: 2005
US
Clear care spray with improved performance
EP 2724714 A3
申请人: HENKEL AG & CO KGAA
优先权: 2012
EP
mRNA, episomal and genomic integrated lentiviral and gammaretroviral vector expression of dimeric immunoglobulin A and polymeric immunoglobulin A to Enable Mucosal and Hematological Based Immunity/Protection via Gene Therapy for Allergens, viruses, HIV, bacteria, pneumonia, infections, pathology associated proteins, systemic pathologies, cancer, toxins and unnatural viruses. CAR engineered and non-CAR engineered immune cell expression of dimeric immunoglobulin A and polymeric immunoglobulin A.
US 2022033851 A1
申请人: SWARTZ ROGER B
优先权: 2021
US
药物
反馈